ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 51

$590K Total Retail Price of All Prescriptions

Rank: 6 out of 51

521 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 521 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 521 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 7,972 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 557 401 1 2
HYDROCODONE-ACETAMINOPHEN 538 251 S3 2 1
LEVOTHYROXINE SODIUM 445 339 3 6
FUROSEMIDE 368 311 4 4
CITALOPRAM HBR 359 234 5 18
METFORMIN HCL 341 247 6 9
OMEPRAZOLE 326 220 7 7
SIMVASTATIN 296 229 8 3
AMLODIPINE BESYLATE 284 238 9 5
TRAMADOL HCL 262 164 10 15
ATENOLOL 194 145 11 17
POTASSIUM CHLORIDE 178 128 12 8
TRAZODONE HCL 172 117 13 32
NEXIUM 151 100 14 20
TAMSULOSIN HCL 144 108 15 37
RANITIDINE HCL 137 95 16 36
CEPHALEXIN 134 96 17 58
PROAIR HFA 128 65 18 44
GABAPENTIN 127 56 19 11
PRAVASTATIN SODIUM 123 100 20 12
WARFARIN SODIUM 122 90 21 19
ADVAIR DISKUS 109 92 22 63
DIGOXIN 108 95 23 45
CARVEDILOL 107 85 24 29
RISPERIDONE 106 55 25 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 74 26 16
VENTOLIN HFA 96 57 27 65
CLOPIDOGREL 95 79 28 30
FENTANYL 94 46 S2 29 102
METOPROLOL SUCCINATE 92 75 30 23
LYRICA 90 71 31 83
PEN NEEDLE 89 66 32 124
BYSTOLIC 88 88 33 136
NAMENDA 84 65 34 56
CYCLOBENZAPRINE HCL 84 41 R 34 35
DOXYCYCLINE HYCLATE 81 66 36 60
ESTRADIOL 80 64 R 37 80
ENALAPRIL MALEATE 77 55 38 78
DILTIAZEM ER 77 68 38 118
AZITHROMYCIN 76 49 40 25
METOPROLOL TARTRATE 74 53 41 10
PLAVIX 74 62 41 51
MIRTAZAPINE 71 33 43 93
MORPHINE SULFATE ER 69 18 S2 44 140
NOVOLOG FLEXPEN 69 54 44 173
LANTUS SOLOSTAR 68 48 46 175
AMLODIPINE BESYLATE-BENAZEPRIL 66 33 47 67
ATORVASTATIN CALCIUM 63 35 48 22
HYDROCHLOROTHIAZIDE 63 60 48 14
SERTRALINE HCL 60 45 50 27
VENLAFAXINE HCL ER 58 20 51 152
DIOVAN 57 49 52 53
PAROXETINE HCL 57 15 52 74
PHENYTOIN SODIUM EXTENDED 57 39 52 117
SPIRIVA 57 45 52 85
DONEPEZIL HCL 57 52 52 62
ROPINIROLE HCL 56 40 57 85
COMBIVENT 56 53 57 101
TERAZOSIN HCL 56 52 57 121
BETAMETHASONE VALERATE 56 44 57 201
FLUCONAZOLE 56 32 57 144
NOVOLOG 56 50 57 201
LOSARTAN POTASSIUM 56 45 57 34
HYDROMORPHONE HCL 55 35 S2 64 128
INSULIN SYRINGE 51 38 65 64
SPIRONOLACTONE 51 40 65 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.